{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": false,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication via swap agreements",
        "Counterparty risk exposure",
        "Complex underlying index (UBS CMCI Ex-Agriculture Ex-Livestock Capped GBP Monthly Hedged Total Return Index)",
        "No capital protection",
        "Issuer credit risk",
        "Exercise and maturity features with contingent redemption"
    ],
    "classification": "complex",
    "supporting_data": "The product is an Open End Tracker Certificate (ETP) issued by UBS AG, not a UCITS fund, and does not provide ownership rights in the underlying assets. The investment objective is to provide a specified entitlement linked to the UBS CMCI Ex-Agriculture Ex-Livestock Capped GBP Monthly Hedged Total Return Index, which is a complex commodity index excluding agriculture and livestock sectors. The product uses synthetic replication through swap agreements with the issuer, exposing investors to counterparty risk. The KIID explicitly states the product is 'not simple and may be difficult to understand' and is intended for investors with advanced knowledge. The product does not have capital protection and can be terminated early by the issuer under certain conditions, potentially resulting in significant losses. The risk indicator is medium (4/7), but the product carries issuer credit risk and derivative counterparty risk. The product involves derivative instruments inherently as part of its structure, not merely for risk management. There is no leverage or inverse exposure, but the synthetic replication and swap usage, combined with the complex underlying index and contingent exercise features, drive the classification as complex under MiFID II. Costs include a management fee of 0.5% p.a. and potential high exit costs if sold before maturity. The product is a debt instrument, exposing investors to issuer insolvency risk. The PRIIPs KID and factsheet confirm the complexity and synthetic nature of the product. Overall, the product's structure, derivative usage, counterparty risk, and complex underlying index justify the 'complex' classification."
}